Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: Studies in the rat

Psychopharmacology

Volumn 151, Issue 2-3, 2000, Pages 152-165

  Flores, C ^a   Stewart, J ^a  

^a and Applied Physiology   (Canada)

Author keywords

Amphetamine; Astrocytes; bFGF; bFGF 2; Dopamine; Glutamate; Neurotrophic factor; Sensitization; Stimulant drug

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CENTRAL STIMULANT AGENT; GLUTAMIC ACID;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; DRUG EFFECT; IMMUNOREACTIVITY; MEDIATOR RELEASE; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SENSITIZATION; STIMULUS RESPONSE;

EID: 0033847219     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000417     Document Type: Review

References (164)

1. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo
2. 2 receptor mRNA expression by striatal astrocytes in culture: In situ hybridization and polymerase chain reaction studies
3. Neurofilament proteins and the mesolimbic dopamine system: Common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area
4. Glial fibrillary acidic protein and the mesolimbic dopamine system: Regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area
5. Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat
6. Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system
7. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine
8. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes
9. 1 receptors of the ventral tegmental area in the behavioral sensitization induced by intraventral tegmental area injections of d-amphetamine
10. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area
11. Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro
12. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine
13. D-Amphetamine-induced behavioral sensitization: Implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation
14. Sensitization to morphine induced by viral-mediated gene transfer
15. AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine
16. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: Variation as a function of lesion size
17. Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys
18. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion
19. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons
20. Relative contribution of endogenous neurotrophins in hippocampal long-term potentiation
21. 2+ responses to AMPA and NMDA in hippocampal neurons
22. Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging
23. 1-like receptors in the ventral tegmental area
24. Effects of the competitive N-methyl-D-aspartate receptor antagonist, CPP, on the development and expression of conditioned hyperactivity and sensitization induced by cocaine
25. Amphetamine psychosis: Individuals, settings, and sequences
26. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists, MK-801 and CPP
27. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia
28. Dendritic spine changes associated with hippocampal long-term synaptic plasticity
29. Endogenous FGF-2 is important for cholinergic sprouting in the denervated hippocampus
30. FGF-2 induces nerve growth factor expression in cultured rat hippocampal neurons
31. Epidermal growth factor exerts neurotrophic effects on dopaminergic and GABAergic CNS neurons: Comparison with basic fibroblast growth factor
32. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: Common adaptations among cross-sensitizing agents
33. Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: Blockade by concurrent treatment with a glutamate antagonist
34. Ovariectomy of adult rats leads to increased expression of astrocytic basic fibroblast growth factor in the ventral tegmental area and in dopaminergic projection regions of the entorhinal and prefrontal cortex
35. Changes in astrocytic basic fibroblast growth factor expression during and after prolonged exposure to escalating doses of amphetamine
36. Requirement of basic fibroblast growth factor for sensitization to amphetamine
37. bFGF induces its own gene expression in astrocytic and hippocampal cell cultures
38. In vivo autoxidation of dopamine in guinea pig striatum increases with age
39. Influence of actinomycin D, a RNA synthesis inhibitor, on long-term potentiation in rat hippocampal neurons in vivo and in vitro
40. Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment
41. Basic FGF in adult rat brain: Cellular distribution and response to entorhinal lesion and fimbria-fornix transection
42. Regulation of astrocyte proliferation by FGF-2 and heparan sulfate in vivo
43. A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain
44. ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ
45. Neurotrophic factors: What are they and what are they doing?
46. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine
47. The growth-activating effect of extracts of adult and embryonic tissues of the rat on fibroblast colonies in culture
48. Environmental and pharmacological sensitization: Effects of repeated administration of systemic or intra-nucleus accumbens cocaine
49. Preexposure sensitizes rats to the rewarding effects of cocaine
50. Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine
51. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor
52. Receptor for neurotransmitters on astrocytes in the mammalian central nervous system
53. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: Involvement of the glutathione system
54. Epidermal growth factor and basic fibroblast growth factor promote the generation of long-term potentiation in the dentate gyrus of anaesthetized rats
55. MK-801 prevents the development of behavioral sensitization during repeated morphine administration
56. Opioid excite dopamine neurons by hyperpolarization of local interneurons
57. Neurotrophin-evoked rapid excitation through TrkB receptors
58. Involvement of NMDA receptor stimulation in the VTA and amygdala in behavioral sensitization to cocaine
59. Time course of extracellular dopamine and behavioral sensitization to cocaine I. Dopamine axon terminals
60. Time course of extracellular dopamine and behavioral sensitization to cocaine II. Dopamine perikarya
61. 1 receptors modulate glutamate transmission in the ventral tegmental area
62. Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area
63. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
64. Amphetamine injection into the A10 dopamine region sensitizes rats to peripheral amphetamine and cocaine
65. Somatodendritic release of endogenous dopamine: In vivo dialysis in the A10 dopamine region
66. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801
67. Amphetamine behavioral sensitization and the excitatory amino acids
68. DNQX blockade of amphetamine behavioral sensitization
69. Calcium channel blockers and behavioral sensitization
70. Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis
71. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction
72. Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: A mechanism to facilitate encoding and circuit maintenance?
73. Metabotropic glutamate receptors are necessary for sensitization by amphetamine
74. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II
75. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine
76. A role for BDNF in the late-phase of hippocampal long-term potentiation
77. Transforming growth factor-beta mediates the neurotrophic effect of fibroblast growth factor-2 on midbrain dopaminergic neurons
78. Anisomycin blocks the late phase of long-term potentiation in the dentate gyrus of freely moving rats
79. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments
80. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine
81. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine
82. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations
83. A protein synthesis-dependent late phase of cerebellar long-term depression
84. Previous exposure to amphetamine increases incentive to obtain the drug: Long lasting effects revealed by the progressive ratio schedule
85. 1 receptor mRNA in projections from the forebrain to the ventral tegmental area
86. 2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells
87. Intracellular injections of EGTA block induction of hippocampal long-term potentiation
88. Mechanisms underlying long-term potentiation of synaptic transmission
89. Long-term potentiation - A decade of progress?
90. Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission
91. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions with amphetamine
92. 2-receptor mechanisms
93. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: Invalidity of the antibodies for tumor angiogenesis
94. Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in cultured hippocampal neurons
95. Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule
96. Promoter regions involved in density-dependent regulation of basic fibroblast growth factor gene expression in human astrocytic cells
97. Transcriptional regulation of fibroblast growth factor-2 expression in human astrocytes: Implications for cell plasticity
98. Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats
99. Intrastriatal infusions of brain derived neurotrophic factor: Retrograde transport and colocalization with dopamine-containing substantia nigra neurons in rat
100. Expression mechanisms underlying NMDA receptor-dependent long-term potentiation
101. Growth factor induction and temporal order in central nervous system repair
102. Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal
103. Basic bFGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice
104. Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons
105. Protection from 1-methyl-4-phenyl-pyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesence phalic cultures with EGF and basic FGE
106. Sensitization to systemic amphetamine produces an enhanced locomotor response to subsequent intra-accumbens amphetamine challenge in rats
107. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats
108. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats
109. Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture
110. Glutamate induces the growth factors NGF, bFGF, the receptor FGF-R1 and c-fos mRNA expression in rat astrocyte culture
111. Factors that predict individual vulnerability to amphetamine self-administration
112. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine
113. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade
114. Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats
115. The neurobiology of amphetamine psychosis: Evidence from studies with an animal model
116. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
117. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine
118. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine
119. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: A microdialysis study in freely moving rats
120. Persistent sensitization of dopamine neurotransmission in ventral striatum nucleus accumbens produced by prior experience with +-amphetamine: A microdialysis study in freely moving rats
121. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system
122. Increase of extracellular glutamate and the expression of Fos-like immunoreactivity in the ventral tegmental area in response to electrical stimulation of the prefrontal cortex
123. Blockade of basic fibroblast growth factor retards recovery from motor cortex injury in rats
124. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area
125. Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo
126. Sensitization to the conditioned rewarding effects of cocaine: Pharmacological and temporal characteristics
127. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons
128. Application of a protein synthesis inhibitor into the ventral tegmental area, but not into the nucleus accumbens, prevents behavioral sensitization to cocaine
129. Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure
130. News on glutamate receptors in glial cells
131. Conditioned stimulus control of the expression of sensitization of the behavioral activating effects of opiate and stimulant drugs
132. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801
133. Conditioning and behavioral sensitization
134. Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine
135. Expression of molecules associated with neuronal plasticity in the striatum after aspiration and thermocoagulatory lesions of the cerebral cortex in adult rats
136. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease
137. Fibroblast growth factor enhances long-term potentiation in the hippocampal slice
138. Biochemistry and molecular biology of fibroblast growth factors
139. Chronic administration of (+)-amphetamine alters the reactivity of midbrain neurons to prefrontal cortex stimulation in the rat
140. Growth of tissues in vitro. IV. The effects of some tissue extracts on the growth of periosteal fibroblasts
141. The development of cocaine-induced behavioral sensitization is affected by discrete quinolinic acid lesions of the prelimbic medial prefrontal cortex
142. Functional heterogeneity of the rat medial prefrontal cortex: Effects of discrete subarea-specific lesions on drug-induced conditioned place preference and behavioural sensitization
143. Fibroblast growth factors: Their role in the central and peripheral nervous system
144. Persistence of the ability of amphetamine preexposure to facilitate acquisition of cocaine self-administration
145. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: An in vivo microdialysis study in the rat
146. 1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area
147. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects
148. The effects of previous exposure to amphetamine on drug-induced locomotion and self-administration of a low dose of the drug
149. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons
150. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system
151. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
152. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization
153. 1 dopamine receptor agonists produce biphasic effects on glutamate efflux in rat ventral tegmental area: Modification by repeated amphetamine administration
154. Amphetamine-induced glutamate efflux in the rat ventral tegmental area is prevented by MK-801, SCH 23390, and ibotenic acid lesions of the prefrontal cortex
155. Differential development of autoreceptor supersensitivity and enhanced dopamine release during amphetamine sensitization
156. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine
157. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: Comparison with N-methyl-D-aspartate antagonists
158. Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys
159. Acute and repeated systemic amphetamine administration: Effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens
160. 2+](i) elevation
161. 1 receptor expression by striatal astrocytes in culture
162. Role of transforming growth factor-beta in long-term synaptic facilitation in Aplysia
163. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors
164. Basic fibroblast growth factor enhances the growth of postnatal neostriatal GABAergic neurons in vitro